首页> 外文期刊>Photoacoustics >Optical-resolution photoacoustic microscopy for monitoring vascular normalization during anti-angiogenic therapy
【24h】

Optical-resolution photoacoustic microscopy for monitoring vascular normalization during anti-angiogenic therapy

机译:光学分辨率光声显微镜,用于监测抗血管生成治疗期间的血管正常化

获取原文
       

摘要

Monitoring the changes in tumor vascularity is important for anti-angiogenic therapy assessment with therapeutic implications. However, monitoring vascularity is quite challenging due to the lack of appropriate imaging techniques. Here, we describe a non-invasive imaging technique using optical-resolution photoacoustic microscopy (OR-PAM) to track vascular changes in prostate cancer treated with an anti-angiogenic agent, DC101, on a mouse ear xenograft model. Approximately 1–3 days after the initial therapy, OR-PAM imaging detected tumor vascular changes such as reduced vessel tortuosity, decreased vessel diameter and homogenized intratumoral vessel distribution. These observations indicated vessel normalization, which was pathologically validated as increased fractional pericyte coverage, functional perfusion and drug delivery of the vessels. After four DC101 interventions, OR-PAM imaging eventually revealed intratumoral vessel regression. Therefore, OR-PAM imaging of the vasculature offers a promising method to study anti-angiogenic drug mechanisms of action in vivo and holds potential in monitoring and guiding anti-angiogenic therapy.
机译:监测肿瘤血管的变化对于评估具有治疗意义的抗血管生成治疗很重要。然而,由于缺乏合适的成像技术,监测血管的形成是非常具有挑战性的。在这里,我们描述了一种非侵入性的成像技术,使用光学分辨率光声显微镜(OR-PAM)来跟踪在小鼠耳异种移植模型上用抗血管生成剂DC101治疗的前列腺癌中的血管变化。初始治疗后约1-3天,OR-PAM成像检测到肿瘤血管变化,例如血管曲折度降低,血管直径减小和瘤内血管分布均匀。这些观察结果表明血管正常化,经病理学证实为增加的周细胞覆盖率,功能性灌注和血管药物输送。经过四次DC101干预后,OR-PAM成像最终显示出肿瘤内血管退化。因此,脉管系统的OR-PAM成像提供了一种研究体内抗血管生成药物作用机制的有前途的方法,并在监测和指导抗血管生成治疗方面具有潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号